Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Jason Drew Smith currently holds 43,305 shares of UroGen Pharma Ltd. (URGN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jason Drew Smith has been a net seller of URGN stock. They have purchased $39.3K and sold $510.2K worth of shares.
Jason Drew Smith's most recent insider trade was on Sep 8, 2025, when they sold 1,520 shares at $19.11 per share.
Jason Drew Smith serves as Executive at UroGen Pharma Ltd. (URGN). They have executed 33 insider transactions totaling $549.4K over their tenure at the company.
Jason Drew Smith holds the position of Executive at UroGen Pharma Ltd., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 5 years and currently hold a stake valued at $0.
Jason Drew Smith has shown a selling trading pattern, with $39.3K in total purchases and $510.2K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Jason Drew Smith was on Jul 28, 2025, when they sold $144.0K worth of URGN shares. This transaction involved 7,522 shares at $19.14 per share.
Jason Drew Smith currently owns 43,305 shares of UroGen Pharma Ltd. (URGN), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Jason Drew Smith's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Jason Drew Smith has 33 Form 4 filings on record as an insider at UroGen Pharma Ltd..
Set alerts for Jason Drew Smith and 40,000+ other insiders.